|
1.
|
Birt AR, Hogg GR and Dubé WJ: Hereditary
multiple fibrofolliculomas with trichodiscomas and acrochordons.
Arch Dermatol. 113:1674–1677. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Nickerson ML, Warren MB, Toro JR, et al:
Mutations in a novel gene lead to kidney tumors, lung wall defects,
and benign tumors of the hair follicle in patients with the
Birt-Hogg-Dubé syndrome. Cancer Cell. 2:157–164. 2002.PubMed/NCBI
|
|
3.
|
Vocke CD, Yang Y, Palvovich CP, et al:
High frequency of somatic frameshift BHD mutations in
Birt-Hogg-Dubé-associated renal tumors. J Natl Cancer Inst.
97:931–935. 2005.PubMed/NCBI
|
|
4.
|
Okimoto K, Sakurai J, Kobayashi T, et al:
A germ-line insertion in the Birt-Hogg-Dubé (BHD) gene gives rise
to the Nihon rat model of inherited renal cancer. Proc Natl Acad
Sci USA. 101:2023–2027. 2004.
|
|
5.
|
Okimoto K, Kouchi M, Matsumoto I, Sakurai
J, Kobayashi T and Hino O: Natural history of the Nihon rat model
of BHD. Curr Mol Med. 4:887–893. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Baba M, Hong SB, Sharma N, et al:
Folliculin encoded by the BHD gene interacts with a binding
protein, FNIP1, and AMPK, and is involved in AMPK and mTOR
signaling. Proc Natl Acad Sci USA. 103:15552–15557. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Hasumi H, Baba M, Hong SB, et al:
Identification and characterization of a novel
folliculin-interacting protein FNIP2. Gene. 415:60–67. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Takagi Y, Kobayashi T, Shiono M, et al:
Interaction of folliculin (Birt-Hogg-Dubé product) with a novel
Fnip1-like (FnipL/Fnip2) protein. Oncogene. 27:5339–5347. 2008.
|
|
9.
|
Baba M, Furihata M, Hong SB, et al:
Kidney-targeted Birt-Hogg-Dubé gene inactivation in a mouse model:
Erk1/2 and Akt-mTOR activation, cell hyperproloferation, and
polycystic kidneys. J Natl Cancer Inst. 100:140–154. 2008.
|
|
10.
|
Hasumi Y, Baba M, Ajima R, et al:
Homozygous loss of BHD causes early embryonic lethality and kidney
tumor development with activation of mTORC1 and mTORC2. Proc Natl
Acad Sci USA. 106:18722–18727. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Preston RS, Philip A, Classens T, et al:
Absence of Birt-Hogg-Dubé gene product is associated with increased
hypoxia-inducible factor transcriptional activity and a loss of
metabolic flexibility. Oncogene. 30:1159–1173. 2010.
|
|
12.
|
Sherr CJ and Roberts JM: CDK inhibitors:
positive and negative regulators of G1-phase progression. Genes
Dev. 13:1501–1512. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Matsumoto I, Kouchi M, Okimoto K, et al:
Establishment and characterization of renal carcinoma cell lines
from a Bhd gene mutant (Nihon) rat. Tumour Biol. 30:249–256. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Niwa H, Yamamura K and Miyazaki J:
Efficient selection for high-expression transfectants with a novel
eukaryotic vector. Gene. 108:193–199. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Fukuda T, Tani Y, Kobayashi T, Hirayama Y
and Hino O: A new western blotting method using polymer
immunocomplexes: detection of Tsc1 and Tsc2 expression in various
cultured cell lines. Anal Biochem. 285:274–276. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Chen RW, Bemis LT, Amato CM, et al:
Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell
lymphoma. Blood. 112:822–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Tetsu O and McCormick F: β-catenin
regulates expression of cyclin D1 in colon carcinoma cells. Nature.
398:422–426. 1999.
|
|
18.
|
Lal A, Mazan-Mamczarz K, Kawai T, Yang X,
Martindale JL and Gorospe M: Concurrent versus individual binding
of HuR and AUF1 to common labile target mRNAs. EMBO J.
23:3092–3102. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Liu Q, Fu H, Sun F, et al: miR-16 family
induces cell cycle arrest by regulating multiple cell cycle genes.
Nucleic Acids Res. 36:5391–5404. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Hua Z, Lv Q, Ye W, et al: miRNA-directed
regulation of VEGF and other angiogenic factors under hypoxia. PLoS
One. 1:e1162006. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Pothof J, Verkaik NS, van Ijcken W, et al:
MicroRNA-mediated gene silencing modulates the UV-induced DNA
damage response. EMBO J. 28:2090–2099. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Jafarifar F, Yao P, Eswarappa SM and Fox
PL: Repression of VEGFA by CA-rich element-binding microRNAs is
modulated by hnRNP L. EMBO J. 30:1324–1334. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Guo H, Ingolia NT, Weissman JS and Bartel
DP: Mammalian microRNAs predominantly act to decrease target mRNA
levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Deshpande A, Pastore A, Deshpande AJ, et
al: 3′UTR mediated regulation of cyclin D1 proto-oncogene. Cell
Cycle. 32:3592–3600. 2009.
|
|
25.
|
Barrreau C, Paillard L and Osborne HB:
AU-rich elements and associated factors: are there unifying
principles? Nucleic Acids Res. 33:7138–7150. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Hamilton BJ, Nichols RC, Tsukamoto H,
Boado RJ, Pardridge WM and Rigby WF: hnRNP A2 and hnRNP L bind the
3′UTR of glucose transporter 1 mRNA and exist as a complex in vivo.
Biochem Biophys Res Commun. 261:646–651. 1999.
|
|
27.
|
Lee DH, Lim MH, Youn DY, Jung SE, Ahn YS,
Tsujimoto Y and Lee JH: hnRNP L binds to CA repeats in the 3′UTR of
bcl-2 mRNA. Biochem Biophys Res Commun. 382:583–587.
2009.PubMed/NCBI
|
|
28.
|
Singh SR, Zhen W, Wang H, et al: The
Drosophila homolog of the human tumor supressor gene BHD
interacts with the JAK-STAT and Dpp signaling pathways in
regulating male germline stem cell maintenance. Oncogene.
25:5933–5941. 2006.
|
|
29.
|
Park SJ, Yang ES, Kim-Ha J and Kim YJ:
Down regulation of extramacrochaetae mRNA by drosophila neural RNA
binding protein Rbp9 which is homologous to human Hu proteins.
Nucleic Acids Res. 26:2989–2994. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Hashemolhosseini S, Nagamine Y, Morley S,
Desrivières S, Mercep L and Ferrari S: Rapamycin inhibition of G1
to S transition is mediated by effect on cyclin D1 mRNA and protein
stability. J Biol Chem. 273:14424–14429. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Manderosian M, Sharma A, Funk AP,
Vartanian R, Mastri J, Jo OD and Gera JF: Tristetraprolin regulates
cyclin D1 and c-Myc mRNA stability in response to rapamycin in an
Akt-dependant manner via p38 MAPK signaling. Oncogene.
25:6277–6290. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Vartanian R, Mastri J, Martin J, et al:
AP-1 regulates cyclin D1 and c-MYC transcription in an
AKT-dependent mannner in response to mTOR inhibition: role of
AIP4/Itch-mediated JUNB degradation. Mol Cancer Res. 9:115–130.
2011. View Article : Google Scholar : PubMed/NCBI
|
